Cardinal Health, Inc. Q3 FY2026 Earnings Release

Cardinal Health, Inc. reported its third quarter fiscal year 2026 results, with revenue increasing 11% to $60.9 billion. GAAP operating earnings decreased 30% to $509 million, and GAAP diluted EPS decreased 20% to $1.69. This decrease was primarily due to a $184 million pre-tax goodwill impairment in the Navista & ION reporting unit. However, non-GAAP operating earnings increased 18% to $956 million, and non-GAAP diluted EPS rose 35% to $3.17. The company raised its fiscal year 2026 non-GAAP EPS guidance to a range of $10.70 to $10.80. The Pharmaceutical and Specialty Solutions segment saw an 11% revenue increase and an 18% profit increase, while the Global Medical Products and Distribution segment revenue remained flat with a 36% profit decrease. The "Other" segment experienced a 31% revenue increase and a 34% profit increase. Cardinal Health also reduced debt and completed an additional $250 million share repurchase.